(Q52980536)

10 May 2018

title

High-dose chemotherapy in germ cell tumours: a large single centre experience. (English)

1 reference

10 May 2018

1 reference

2

1 reference

10 May 2018

author name string

Rick O

1

1 reference

10 May 2018

Kingreen D

3

1 reference

10 May 2018

Schwella N

4

1 reference

10 May 2018

Krusch A

5

1 reference

10 May 2018

Schleicher J

6

1 reference

10 May 2018

Kirsch A

7

1 reference

10 May 2018

Huhn D

8

1 reference

10 May 2018

Siegert W

9

1 reference

10 May 2018

publication date

1 November 1998

1 reference

10 May 2018

European Journal of Cancer

published in

1 reference

10 May 2018

volume

34

1 reference

10 May 2018

issue

12

1 reference

10 May 2018

page(s)

1883-1888

1 reference

10 May 2018

Testicular germ-cell cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Salvage treatment in male patients with germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Prognosis after salvage treatment for unselected male patients with germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

Long-term effects of chemotherapy in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900272-X

7 January 2021

10.1016/S0959-8049(98)00272-X

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018